- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 28.74M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $441.44M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $669.44M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.12B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.1B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.3B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.28B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $821.44M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.9B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.1B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $5.5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $152.68M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $671.54M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $558.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.20 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.32 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $44.08M |
| Net Income | Q1 2025 · Mar 31, 2024 | $102.59M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $104.07M |
| Revenue | Q1 2025 · Mar 31, 2024 | $511.04M |